Erasca (ERAS) Stock Forecast & Price Target

Compare

271 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ERAS Analyst Ratings

Strong Buy

6 Buy

0 Hold

0 Sell

Based on 6 analysts giving stock ratings to

Erasca

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ERAS Stock 12 Month Forecast

Average Price Target

$4.40

▲(175.00%Upside)

Based on 6 Wall Street analysts offering 12 month price targets for Erasca in the last 3 months. The average price target is $4.40 with a high forecast of $6.00 and a low forecast of $3.00. The average price target represents a 175.00% change from the last price of $1.60.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","7":"$7","1.75":"$1.75","3.5":"$3.5","5.25":"$5.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$6.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$4.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1.75,3.5,5.25,7],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2024","6":"Aug<br/>2024","9":"Jan<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.49,1.8369230769230769,2.1838461538461535,2.5307692307692307,2.8776923076923078,3.2246153846153844,3.571538461538461,3.918461538461538,4.265384615384615,4.612307692307692,4.959230769230769,5.306153846153846,5.653076923076923,{"y":6,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.49,1.7138461538461538,1.9376923076923078,2.161538461538462,2.3853846153846154,2.609230769230769,2.8330769230769235,3.056923076923077,3.2807692307692307,3.504615384615385,3.7284615384615387,3.9523076923076923,4.176153846153847,{"y":4.4,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.49,1.606153846153846,1.7223076923076923,1.8384615384615384,1.9546153846153846,2.0707692307692307,2.186923076923077,2.3030769230769232,2.419230769230769,2.5353846153846153,2.651538461538461,2.7676923076923075,2.8838461538461537,{"y":3,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.11,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.17,"date":1704067200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.72,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.55,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.16,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.09,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.07,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.59,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.72,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.51,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.37,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.2,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.49,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$6.00

Average Price Target$4.40

Lowest Price Target$3.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Alec StranahanBank of America Securities

Bank of America Securities

$5→$4

Buy

150.00%

Upside

Reiterated

05/15/25

Bank of America Securities Sticks to Their Buy Rating for Erasca (ERAS)

Andres Y. MaldonadoH.C. Wainwright

H.C. Wainwright

Buy

275.00%

Upside

Reiterated

05/14/25

Erasca's Strategic Advancements and Promising RAS-Targeting Therapies Justify Buy Rating

Michael SchmidtGuggenheim

Guggenheim

$3.5→$3

Buy

87.50%

Upside

Reiterated

05/13/25

Erasca price target lowered to $3 from $3.50 at GuggenheimErasca price target lowered to $3 from $3.50 at Guggenheim

Sean LaamanMorgan Stanley

Morgan Stanley

Buy

150.00%

Upside

Reiterated

03/31/25

Morgan Stanley Keeps Their Buy Rating on Erasca (ERAS)

Anupam RamaJ.P. Morgan

J.P. Morgan

―

Buy

―

Reiterated

03/28/25

Erasca (ERAS) Gets a Buy from J.P. Morgan

Laura PrendergastRaymond James

Raymond James

Buy

212.50%

Upside

Initiated

03/26/25

Analysts Are Bullish on Top Healthcare Stocks: Vera Therapeutics (VERA), Erasca (ERAS)

Maury RaycroftJefferies

Jefferies

Buy

275.00%

Upside

Initiated

11/18/24

Jefferies starts Erasca Inc (ERAS) at BuyJefferies analyst Maury Raycroft initiates coverage on Erasca Inc (NASDAQ: ERAS) with a Buy rating and a price target of $6.00.

Naureen QuibriaCapital One Financial

Capital One Financial

Buy

150.00%

Upside

Assigned

10/25/24

Erasca's Naporafenib Progress and Strategic Focus Bolster Buy Rating

Chris ShibutaniGoldman Sachs

Goldman Sachs

$4→$3

Buy

87.50%

Upside

Reiterated

08/13/24

Erasca Inc. Poised for Growth: Buy Rating Maintained Amidst Promising Trial Updates and Solid Financials

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Alec StranahanBank of America Securities

Bank of America Securities

$5→$4

Buy

150.00%

Upside

Reiterated

05/15/25

Bank of America Securities Sticks to Their Buy Rating for Erasca (ERAS)

Andres Y. MaldonadoH.C. Wainwright

H.C. Wainwright

Buy

275.00%

Upside

Reiterated

05/14/25

Erasca's Strategic Advancements and Promising RAS-Targeting Therapies Justify Buy Rating

Michael SchmidtGuggenheim

Guggenheim

$3.5→$3

Buy

87.50%

Upside

Reiterated

05/13/25

Erasca price target lowered to $3 from $3.50 at GuggenheimErasca price target lowered to $3 from $3.50 at Guggenheim

Sean LaamanMorgan Stanley

Morgan Stanley

Buy

150.00%

Upside

Reiterated

03/31/25

Morgan Stanley Keeps Their Buy Rating on Erasca (ERAS)

Anupam RamaJ.P. Morgan

J.P. Morgan

―

Buy

―

Reiterated

03/28/25

Erasca (ERAS) Gets a Buy from J.P. Morgan

Laura PrendergastRaymond James

Raymond James

Buy

212.50%

Upside

Initiated

03/26/25

Analysts Are Bullish on Top Healthcare Stocks: Vera Therapeutics (VERA), Erasca (ERAS)

Maury RaycroftJefferies

Jefferies

Buy

275.00%

Upside

Initiated

11/18/24

Jefferies starts Erasca Inc (ERAS) at BuyJefferies analyst Maury Raycroft initiates coverage on Erasca Inc (NASDAQ: ERAS) with a Buy rating and a price target of $6.00.

Naureen QuibriaCapital One Financial

Capital One Financial

Buy

150.00%

Upside

Assigned

10/25/24

Erasca's Naporafenib Progress and Strategic Focus Bolster Buy Rating

Chris ShibutaniGoldman Sachs

Goldman Sachs

$4→$3

Buy

87.50%

Upside

Reiterated

08/13/24

Erasca Inc. Poised for Growth: Buy Rating Maintained Amidst Promising Trial Updates and Solid Financials

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Erasca

1 Month

xxx

Success Rate

4/10 ratings generated profit

Average Return

+0.46%

reiterated a xxx

rating 28 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 40.00% of your transactions generating a profit, with an average return of +0.46% per trade.

3 Months

xxx

Success Rate

6/10 ratings generated profit

Average Return

-0.64%

reiterated a xxx

rating 28 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of -0.64% per trade.

1 Year

Andres Y. MaldonadoH.C. Wainwright

Success Rate

5/10 ratings generated profit

Average Return

-6.16%

reiterated a buy rating 28 days ago

Copying Andres Y. Maldonado's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -6.16% per trade.

2 Years

xxx

Success Rate

3/7 ratings generated profit

Average Return

-15.81%

reiterated a xxx

rating 27 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 42.86% of your transactions generating a profit, with an average return of -15.81% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ERAS Analyst Recommendation Trends

Rating

Nov 24

Jan 25

Mar 25

Apr 25

May 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ERAS has received 12 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ERAS average Analyst price target in the past 3 months is 4.40.

Each month's total comprises the sum of three months' worth of ratings.

ERAS Financial Forecast

ERAS Earnings Forecast

Next quarter’s earnings estimate for ERAS is -$0.12 with a range of -$0.14 to -$0.10. The previous quarter’s EPS was -$0.11. ERAS beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year ERAS has Outperformed its overall industry.

No data currently available

ERAS Sales Forecast

Next quarter’s sales forecast for ERAS is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. ERAS beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.45% of the time in the same period. In the last calendar year ERAS has Preformed in-line its overall industry.

ERAS Stock Forecast FAQ

What is ERAS’s average 12-month price target, according to analysts?

Based on analyst ratings, Erasca, Inc.’s 12-month average price target is 4.40.

What is ERAS’s upside potential, based on the analysts’ average price target?

Erasca, Inc. has 175.00% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ERAS a Buy, Sell or Hold?

Erasca, Inc. has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.

What is Erasca, Inc.’s price target?

The average price target for Erasca, Inc. is 4.40. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $6.00 ,the lowest forecast is $3.00. The average price target represents 175.00% Increase from the current price of $1.6.

What do analysts say about Erasca, Inc.?

Erasca, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of ERAS?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Erasca (ERAS) Stock Forecast & Price Target

ERAS Analyst Ratings

ERAS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Erasca

ERAS Analyst Recommendation Trends

ERAS Financial Forecast

ERAS Earnings Forecast

ERAS Sales Forecast

ERAS Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts